Stryker Corporation (SYK) Opens 140,000-Sq-Ft R&D Hub in India to Accelerate AI and Robotics

We recently compiled a list of the 12 Best Healthcare Stocks to Buy and Hold for 5 Years. Stryker Corporation is one of them.

Stryker Corporation (NYSE:SYK), a global leader in medical technology, has strengthened its innovation footprint with the opening of a 140,000-square-foot research and development center in Bangalore, India. The facility will focus on robotics, artificial intelligence (AI), digital health, and product security, aiming to accelerate product development and strengthen collaboration with healthcare providers, particularly in emerging markets. By leveraging India’s talent pool and cost efficiencies, SYK is positioning itself for sustainable growth and stronger global margins.

Further advancing its technology-driven strategy, Stryker Corporation (NYSE:SYK) announced a partnership with Siemens Healthineers to co-develop a robotic system for neurovascular procedures. The initiative targets greater precision and efficiency in treating strokes and aneurysms, underscoring the firm’s expansion into robotics and integrated digital platforms within the neurotechnology sector.

The business also broadened its orthopaedics portfolio with the launch of the Incompass Total Ankle System at the 2025 American Orthopaedic Foot & Ankle Society (AOFAS) meeting in September. This rollout reflects ongoing investment in specialized medical solutions to address diverse patient needs.

Financially, Stryker Corporation (NYSE:SYK) continues to deliver strong results, with recent quarterly earnings surpassing analyst estimates. The company reaffirmed its optimistic full-year 2025 earnings guidance of $13.40 to $13.60 per share, supported by innovation, global expansion, and a robust product pipeline.

While we acknowledge the potential of SYK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy NOW 

Disclosure: None.